176 reports of this reaction
12.2% of all COBICISTAT reports
#1 most reported adverse reaction
DRUG INTERACTION is the #1 most commonly reported adverse reaction for COBICISTAT, manufactured by Gilead Sciences, Inc.. There are 176 FDA adverse event reports linking COBICISTAT to DRUG INTERACTION. This represents approximately 12.2% of all 1,443 adverse event reports for this drug.
Patients taking COBICISTAT who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is a frequently reported adverse event for COBICISTAT, accounting for a significant proportion of all reports.
In addition to drug interaction, the following adverse reactions have been reported for COBICISTAT:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 176 FDA reports for COBICISTAT. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 12.2% of all adverse event reports for COBICISTAT, making it one of the most commonly reported side effect.
If you experience drug interaction while taking COBICISTAT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.